ADIL Med Monitor

APhA DrugInfoLine, published by the American Pharmacists Association, provides timely, relevant, interpreted drug news and information.

[ADIL Med Monitor @MedicationMon]

FDA approves voxelotor (Oxbryta) for sickle cell disease
https://t.co/NSLaWHvPeH

[ADIL Med Monitor @MedicationMon]

Adalimumab-afzb, biosimilar to Humira, approved for multiple inflammatory conditions
https://t.co/nBHgiqWXRQ

[ADIL Med Monitor @MedicationMon]

Acalabrutinib now approved for treatment of adults with CLL, SLL
https://t.co/I17aFL9wvi

[ADIL Med Monitor @MedicationMon]

Riluzole oral film approved for patients with ALS
https://t.co/Yu5PGzvMIi

[ADIL Med Monitor @MedicationMon]

Givosiran approved for acute hepatic porphyria
https://t.co/cP1dCl8aZd

[ADIL Med Monitor @MedicationMon]

Cefiderocol approved to treat complicated urinary tract infections
https://t.co/tk5U06m7V3

[ADIL Med Monitor @MedicationMon]

FDA approves cenobamate tablets for adults with partial-onset seizures
https://t.co/0pqhsK7QME

[ADIL Med Monitor @MedicationMon]

Crizanlizumab-tmca (Adakveo), first targeted therapy, approved for patients with painful complication of sickle cell disease
https://t.co/TVZ0Mkrt5z

[ADIL Med Monitor @MedicationMon]

New agent, #zanubrutinib (#Brukinsa), targets mantle cell lymphoma in adults who've received at least one prior therapy
https://t.co/Fy0WAqtil9

[ADIL Med Monitor @MedicationMon]

FDA approves luspatercept–aamt (Reblozyl), first therapy for beta thalassemia, a rare blood disorder
https://t.co/qcuwI8Nq9v

[ADIL Med Monitor @MedicationMon]

Sandoz receives approval for pegfilgrastim biosimilar
https://t.co/1oSVvB4qpO

[ADIL Med Monitor @MedicationMon]

FDA approves Talicia, three-drug combination to treat H. pylori infection
https://t.co/tBmQ9jvZXJ

[ADIL Med Monitor @MedicationMon]

FDA approves teriparatide injection (Bonsity) for osteoporosis
https://t.co/IBv0mulXgG

[ADIL Med Monitor @MedicationMon]

First asenapine transdermal patch approved for treatment of adults with schizophrenia
https://t.co/AIbSXCRQD9

[ADIL Med Monitor @MedicationMon]

FDA approves Xofluza for people at high risk of developing flu-related complications
https://t.co/7NvtCvloxU

[ADIL Med Monitor @MedicationMon]

First topical formulation of minocycline approved to treat acne
https://t.co/fJylWMadk2

[ADIL Med Monitor @MedicationMon]

Ravulizumab-cwvz approved for atypical hemolytic uremic syndrome
https://t.co/uoIAK3ICsU

[ADIL Med Monitor @MedicationMon]

Ustekinumab has new indication for treatment of adults with ulcerative colitis
https://t.co/XJepSD7Vu9

[ADIL Med Monitor @MedicationMon]

Niraparib approved for late-line treatment of women with recurrent ovarian cancer
https://t.co/jG8sv2Bf6t

[ADIL Med Monitor @MedicationMon]

FDA approves delafloxacin for treatment of community-acquired bacterial pneumonia
https://t.co/h0zSsPtCjZ